GemPharmatech Co., Ltd.

¥32.70As of Sun 8 Nov 2026, 12:00 UTC
SSE:688046Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 14.29%
Div yield 0.67%
ROE 8.96%
Biotechnology
Beta (5Y) 0.97
PE TTM 65.45
TSR TTM 86.68%
Mkt cap ¥13.38B
ROIC 13.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥32
(2.17%)
(37.44%)
Hold 11|3|8|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.51
0.51
0.56
0.56
11.22%
2.97%
19.64%
6.75%
Revenue¥M
703.3
733.0
745.6
736.5
12.03%
11.96%
13.03%
7.35%
Peers (US$2.006B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
16.95
0.153
0.153
EBIT/Intx
0.583
1.002
1.155
Own earn%
247.69
60.20
42.61
Sh yield%
34.36
15.35
14.05
Owners
Insiders/Inst%
6.08
67.16
Short interest%
5.19
SBC / revenue%
4.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
22–27
$1 testx
0.1
Incr. ROIC%
0